Skip to content

The effect of transcranial ultrasound stimulation on the M1 cortical plasticity of methamphetamine addicts

The effect of transcranial ultrasound stimulation on the M1 cortical plasticity of methamphetamine addicts

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039290
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-25
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction

Interventions

Group 1:HC left-M1 TUS intervention
Group 2:HC left-M1 sham TUS intervention
Group 3:MA left-M1 TUS intervention
Group 4:MA left-M1 sham TUS intervention

Sponsors

Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: 1. Agree to receive tus intervention; 2. Agree and have the ability to learn the process, including adequate cognitive understanding level; 3. Aged 18-60 years; 4. Junior high school or above education level. Patients with methamphetamine use disorder: 1. Meet the diagnostic criteria of substance addiction in dsm-5; 2. Aged 18-60 years; 3. Junior high school education or above; 4. Willing to participate in this study and sign informed consent. 5. The time of drug abuse is more than one year, the frequency of drug use is more than once a week, and the amount of drug use is more than 1 gram per month; 6. Depressive symptoms.

Exclusion criteria

Exclusion criteria: Healthy subjects: 1. Meet the current criteria of severe depression, bipolar disorder, schizophrenia, any mental illness (including drug-induced mental illness) and current drug-induced emotional disorder; 2. Suffering from delusion, dementia, amnesia, obsessive-compulsive disorder, post-traumatic stress disorder, anxiety disorder, any personality disorder and cognitive or dissociative disorder; 3. Serious physical disease, history of heart disease, pacemaker or implanted drug pump, etc.; 4. Serious negative ideas and behaviors; 5. Pregnant and lactating women; 6. There are metal implants, cochlear implants, increased intracranial pressure, brain trauma, skull insufficiency, encephalitis, brain tumors in the brain; 7. Have any nervous system disease, epilepsy, Parkinson's disease, stroke, etc., have family history of epilepsy, use anticonvulsant drugs; 8. Suffering from cardiovascular and cerebrovascular diseases such as hypertension; 9. There were cerebral calcification and cerebral microbleeds. 10. Obesity, BMI > 35; 11. Sleep deprivation; 12. In test 1, the amplitude of MEP in baseline state fluctuated more than 15%. Patients with drug use disorder: 1. Meet the current criteria of severe depression, bipolar disorder, schizophrenia, any mental illness (including drug-induced mental illness) and current drug-induced emotional disorder; 2. Drug abuse is not a single drug, but a serious mixed use; 3. Suffering from delusion, dementia, amnesia, obsessive-compulsive disorder, post-traumatic stress disorder, anxiety disorder, any personality disorder and cognitive or dissociative disorder; 4. Serious physical disease, history of heart disease, pacemaker or implanted drug pump, etc.; 5. Serious negative ideas and behaviors; 6. Pregnant and lactating women; 7. There are metal implants, cochlear implants, increased intracranial pressure, brain trauma, skull insufficiency, encephalitis, brain tumors in the brain; 8. Have any nervous system disease, epilepsy, Parkinson's disease, stroke, etc., have family history of epilepsy, use anticonvulsant drugs; 9. Suffering from cardiovascular and cerebrovascular diseases such as hypertension; 10. There were cerebral calcification and cerebral microbleeds. 11. Obesity, BMI > 35; 12. Sleep deprivation; 13. In test 1, the amplitude of MEP in baseline state fluctuated more than 15%.

Design outcomes

Primary

MeasureTime frame
MEP;

Secondary

MeasureTime frame
Behavioral task indicator;RMT;

Countries

China

Contacts

Public ContactYuan Tifei

Shanghai Mental Health Center

ytf0707@126.com+86 18614086633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026